Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | CASP1 | P29466 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | CASP7 | P55210 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.44 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10460557 | 0.91 | HSD11B1 (0.46) | PDE10ARAB9AKDM4ENPC1MAPT | |
| SCHEMBL27551421 | 0.90 | HSD11B1 (0.47) | PDE10ARAB9AKDM4ENPC1MAPT | |
| SCHEMBL3134468 | 0.88 | HSD17B10 (0.46) | RAB9AKDM4ENPC1MAPTALDH1A1 | |
| SCHEMBL3142147 | 0.88 | HSD17B10 (0.46) | RAB9AKDM4ENPC1MAPTALDH1A1 | |
| SCHEMBL28746601 | 0.88 | HSD17B10 (0.46) | RAB9AKDM4ENPC1MAPTALDH1A1 | |
| SCHEMBL30273419 | 0.87 | HSD17B10 (0.45) | RAB9AKDM4ENPC1MAPTALDH1A1 | |
| SCHEMBL28095643 | 0.87 | HSD17B10 (0.45) | RAB9AKDM4ENPC1MAPTALDH1A1 | |
| SCHEMBL17600561 | 0.87 | HSD17B10 (0.45) | RAB9AKDM4ENPC1MAPTALDH1A1 | |
| SCHEMBL4445451 | 0.87 | KDM4E (0.47) | PDE10ARAB9AKDM4ENPC1MAPT | |
| SCHEMBL19990291 | 0.84 | RIPK1 (0.46) | PDE10ARAB9AKDM4ENPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1348711-B1 | LUMINESCENT ELEMENT AND DISPLAY | CANON KK (JP) | 2018-06-13 | — | — | EP | disclosed |
| EP-1889891-B1 | Luminescence device and display apparatus | CANON KK (JP) | 2017-11-22 | — | — | EP | disclosed |
| US-20150076478-A1 | LUMINESCENCE DEVICE AND DISPLAY APPARATUS | CANON KK (JP) | 2015-03-19 | — | — | US | disclosed |
| US-8920943-B2 | Luminescence device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2014-12-30 | — | — | US | disclosed |
| US-7687155-B2 | Comprises iridium complexes, coordination compounds; red phosphorescence; high efficiency | CANON KABUSHIKI KAISHA (JP) | 2010-03-30 | — | — | US | disclosed |
| US-20090184634-A1 | LUMINESCENCE DEVICE AND DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2009-07-23 | — | — | US | disclosed |
| US-7544426-B2 | Comprises iridium complexes, coordination compounds; red phosphorescence; high efficiency | CANON KABUSHIKI KAISHA (JP) | 2009-06-09 | — | — | US | disclosed |
| US-7527879-B2 | Luminescence device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2009-05-05 | — | — | US | disclosed |
| CN-100375749-C | Luminescence device and display apparatus | CANON KK (JP) | 2008-03-19 | — | — | CN | disclosed |
| EP-1889891-A2 | Luminescence device and display apparatus | Canon Kabushiki Kaisha (JP) | 2008-02-20 | — | — | EP | disclosed |
| EP-1881050-A2 | Luminescence device and display apparatus | Canon Kabushiki Kaisha (JP) | 2008-01-23 | — | — | EP | disclosed |
| US-20070216294-A1 | LUMINESCENCE DEVICE AND DISPLAY APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2007-09-20 | — | — | US | disclosed |
| US-20070212570-A1 | Comprises iridium complexes, coordination compounds; red phosphorescence; high efficiency | CANON KABUSHIKI KAISHA (JP) | 2007-09-13 | — | — | US | disclosed |
| US-7147935-B2 | Such as tetrakis(1-(5-heptyloxyphenyl)isoquinoline-C2,N) (pu-dichloro) iridium (III); for red luminescence; graphic arts | CANON KABUSHIKI KAISHA (JP) | 2006-12-12 | — | — | US | disclosed |
| CN-1285601-C | Light emitting device and display | CANON KK (JP) | 2006-11-22 | — | — | CN | disclosed |
| US-20060177694-A1 | Comprises iridium complexes, coordination compounds; red phosphorescence; high efficiency | CANON KABUSHIKI KAISHA (JP) | 2006-08-10 | — | — | US | disclosed |
| CN-1781925-A | Luminescence device and display apparatus | CANON KK (JP) | 2006-06-07 | — | — | CN | disclosed |
| CN-1474826-A | Light emitting device and display | ������������ʽ���� | 2004-02-11 | — | — | CN | disclosed |
| EP-1348711-A1 | LUMINESCENT ELEMENT AND DISPLAY | CANON KABUSHIKI KAISHA (JP) | 2003-10-01 | — | — | EP | disclosed |
| US-20030068526-A1 | Such as tetrakis(1-(5-heptyloxyphenyl)isoquinoline-C2,N) (pu-dichloro) iridium (III); for red luminescence; graphic arts | CANON KABUSHIKI KAISHA (JP) | 2003-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060177694-A1 | Comprises iridium complexes, coordination compounds; red phosphorescence; high efficiency | AP3M1, MLEC, MLX | PDE10A 3190/4885RAB9A 1333/4885KDM4E 3317/4885 |
| US-20090184634-A1 | LUMINESCENCE DEVICE AND DISPLAY APPARATUS | SOD1, NLRP1, LUC7L2 | PDE10A 2516/4885RAB9A 2177/4885KDM4E 4129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.